Chronic Kidney Disease

A literature review pointed out the limited current research that has been conducted on how to manage pruritus in patients with chronic kidney disease (CKD) treated with hemodialysis, suggesting that more data is needed to improve symptom burden in these patients.

A new review article shows diabetes and hypertension are linked with arrhythmia and chronic kidney disease (CKD), but several other less common causes also exist.

Investigators confirmed an association between fatty liver disease related to metabolic dysfunction (MAFLD) and chronic kidney disease (CKD), and stressed a greater focus on treating MAFLD is needed to help manage risks.

Chronic kidney disease (CKD) and diabetes were associated with a higher risk of neurocognitive decline, but kidney disease stage did not appear to affect risk.

Incident end-stage kidney disease cases more than doubled among Asian individuals, and prevalent cases more than tripled for Asian, Native Hawaiian or other Pacific Islander, and Hispanic individuals.

Finerenone (Kerendia) was found to reduce risk of heart failure and improve other cardiovascular outcomes in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D) regardless of heart failure history.

A recent review found that patients with chronic kidney disease (CKD) have fewer daily steps than the recommended physical activity benchmark, which has implications for their CKD prognosis.

Robert Gabbay, MD, PhD, of the American Diabetes Association (ADA), talks about the impact that finerenone could have on patients with kidney disease and diabetes.

A recent review found that families caring for a loved one with kidney failure lack information and continuity of care from health care professionals.

Robert Gabbay, MD, PhD, of the American Diabetes Association (ADA), breaks down the reasoning behind the organization's decision to add Bayer's Kerendia (finerenon) as a recommended drug for kidney disease prevention.

A quasiexperimental study conducted in China provides strong evidence that air pollution is linked to kidney impairment, which points to the importance of policy efforts to ensure clean air.

Robert Gabbay, MD, PhD, of the American Diabetes Association, explains why a section on chronic kidney disease management was added to the ADA's 2022 standard of care guidelines.

The organization announced a partnership with over 1000 nephrology providers to help implement CMS’ new Kidney Care Choices models beginning this year.

Adding risk factors specific to patients with chronic kidney disease (CKD) to risk prediction models for cardiovascular disease (CVD) could improve risk prediction capabilities for a population of patients often subject to invasive diagnostic procedures, investigators concluded.

Patients with chronic kidney disease (CKD) and their caregivers who have participated in CKD research shared factors that may encourage or discourage others from enrolling in clinical studies, highlighting the ways that investigators can better involve patients in research.

Data from a 10-year follow-up study showed declining kidney function is significantly associated with dementia risk among older adults.

Robert Gabbay, MD, PhD, of the American Diabetes Association (ADA), discusses the development process for the section of ADA guidelines that touches on chronic kidney disease (CKD) management in patients with diabetes.

The American Diabetes Association (ADA) has added a new section to their 2022 Standard of Care guidelines to assist clinicians in managing and preventing the presence of chronic kidney disease and related complications in patients with diabetes.

Although men and women with advanced kidney disease experienced physical and mental declines in health-related quality of life (QOL), men’s declines occurred at a significantly faster rate, researchers concluded.

More nutritional care may be needed for elderly patients with chronic kidney disease (CKD) who are ingesting higher-than-recommended amounts of protein, investigators concluded.

A study comparing 4 different artificial intelligence (AI) models found that some models were better than others at detecting early-stage chronic kidney disease (CKD), when patients do not experience visible symptoms.

Investigators offered insight into disparities between countries regarding chronic kidney disease burden and suggestions on how those disparities can be addressed.

Risk of recurrent venous thromboembolism (VTE) in patients with chronic kidney disease (CKD) and VTE was significantly reduced in those who were treated with apixaban vs warfarin, investigators concluded.

Insulin resistance may become a future target of treatment in the chronic kidney disease (CKD) population because of the several mechanisms in patients that contribute to increasing resistance, authors of a review concluded.

A focus group consisting of patients with chronic kidney disease (CKD) as well as CKD providers and researchers shared what they deem necessary and helpful to include in future mobile CKD management applications.

The top 5 most-read chronic kidney disease stories of 2021 on AJMC.com significantly focused on aiding physicians with determining patient risk of developing the disease or experiencing renal complications.

Pulse pressure was found to have a significant association with chronic kidney disease (CKD), indicating that changes in pulse pressure could serve as a predictive marker for disease progression.

Patients with chronic kidney disease (CKD) undergoing hemodialysis experienced a greater degree of psychological distress during the COVID-19 pandemic compared with patients treated with peritoneal dialysis, investigators found.

Patients who have experienced acute kidney injury (AKI) reported experiencing significant impacts on aspects of their physical and emotional health, demonstrating the different ways that AKI episodes influence patients’ health-related quality of life.